Sponsor pipeline

Imviva Bio clinical trial pipeline

Get alerts when Imviva Bio's trials change

2 active trials 1 recruiting 4 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-20
Enrollment increased: 54 → 118 participants
Trial arms changed: 1 → 2
NCT07070219 A Study of CTD402 in T-ALL/LBL Patients · Phase 1/2

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-08-24 NCT07783269 A Basket Study of CTA313 in Participants With Active Autoimmune Diseases Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
1
Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT07070219 A Study of CTD402 in T-ALL/LBL Patients Acute Lymphocytic Leukemia Refractory Recruiting 2026-08-19
Phase 1
NCT07783269 A Basket Study of CTA313 in Participants With Active Autoimmune Diseases Systemic Lupus Erthematosus (SLE) Not Yet Recruiting 2026-08-24

Disease areas by active trials

Leukemia (1) · Acute Lymphoblastic Leukemia (ALL) (1) · Multiple Sclerosis (1) · Lupus (SLE) (1)

Get alerts when Imviva Bio's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free